Cerulean, Novartis deal

Cerulean and Daré will merge in a stock deal; the resulting company will retain Daré's name. Daré’s current CEO, Sabrina Martucci

Read the full 218 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE